Clonazepam Orally Disintergrating Tablets recall
CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets (10 blister cards of 6 tablets each), TEVA PHARMACEUTICALS USA, Sellersville PA…
Why was Clonazepam Orally Disintergrating Tablets recalled?
Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot # 32900136A, Exp. 05/14
- Product
- CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets (10 blister cards of 6 tablets each), TEVA PHARMACEUTICALS USA, Sellersville PA…
- Recalling firm
- Teva Pharmaceuticals USA, Inc.
- Quantity
- 3 boxes
- Distribution
- NC
- Recall date
- April 10, 2013
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)